Benzinga

Benzinga

Benzinga

martes, agosto 18

Cadrenal Therapeutics Inc

CVKDNASDAQ
Trade with Public
Trade with Public
$1.71
-0.05-2.84%
al cierre: Aug 18, 5:00 PM EST
$1.66
-0.0475-2.78%
After hour: 5:46 PM EST
Ganancias: Los beneficios de Q2 2026 se publicaron el jue ago 13th, después del cierre del mercado
Panorámica generalNoticiasPrevisión de beneficiosEventosPrecios objetivoFinanzasSentimientoPropiedadCompararInforme de acciones

Cadrenal Therapeutics Financials

Cadrenal Therapeutics (CVKD) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Cadrenal Therapeutics Q2 EPS $(1.14) Beats $(1.42) Estimate

Benzinga Newsdesk

PRO
Cadrenal Therapeutics Q1 EPS $(1.04) Beats $(1.62) Estimate

Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(1.04) per share which beat the analyst consensus estimate of $(1.62) by 35.8 percent. This is a 50.24 percent increase over losses of $(2.09) per share
Benzinga Newsdesk

PRO
Cadrenal Therapeutics Q4 EPS $(1.41) Misses $(1.18) Estimate

Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(1.41) per share which missed the analyst consensus estimate of $(1.18) by 19.49 percent. This is a 49.64 percent increase over losses of $(2.80) per
Benzinga Newsdesk

PRO
Cadrenal Therapeutics Q3 EPS $(1.31) Beats $(1.53) Estimate

Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(1.31) per share which beat the analyst consensus estimate of $(1.53) by 14.21 percent. This is a 39.91 percent increase over losses of $(2.18) per share
Benzinga Newsdesk

PRO
Cadrenal Therapeutics Q2 EPS $(1.87) Misses $(1.60) Estimate

Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(1.87) per share which missed the analyst consensus estimate of $(1.60) by 17.09 percent. This is a 16.89 percent increase over losses of $(2.25) per
Benzinga Newsdesk

PRO
Cadrenal Therapeutics Q1 EPS $(2.09) Misses $(1.25) Estimate

Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(2.09) per share which missed the analyst consensus estimate of $(1.25) by 67.2 percent. This is a 39.33 percent decrease over losses of $(1.50) per share
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved